Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now displays 'Results Submitted' to indicate that trial results have been posted, replacing the previous 'No Results Posted' notification. The change clarifies the availability of outcomes for users reviewing the trial.
    Difference
    0.1%
    Check dated 2026-03-25T21:00:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:05.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:24:34.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice as well as the prior Revision: v3.4.1 banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:51:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Adds a site-wide funding/operating status notice and updates versioning to v3.4.1, removing the previous v3.4.0 note.
    Difference
    0.5%
    Check dated 2026-02-04T04:43:09.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Show glossary option added and capitalization adjustments for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a revision tag to v3.4.0. Deletions remove lowercase variants and revert to an older revision label (v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T02:28:31.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.